Matthew Fraser Ahearn Sells 4,144 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 4,144 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $18.84, for a total value of $78,072.96. Following the sale, the chief operating officer owned 269,176 shares of the company’s stock, valued at $5,071,275.84. This trade represents a 1.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.68, for a total value of $296,190.08.

Shoulder Innovations Trading Down 3.8%

Shares of Shoulder Innovations stock opened at $17.96 on Thursday. The stock has a fifty day simple moving average of $14.71 and a 200 day simple moving average of $14.42. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $19.79. The company has a market capitalization of $372.55 million and a P/E ratio of -0.11. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.03. The business had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. On average, sell-side analysts anticipate that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current fiscal year.

Institutional Trading of Shoulder Innovations

A number of institutional investors have recently added to or reduced their stakes in SI. TimesSquare Capital Management LLC bought a new position in Shoulder Innovations in the 3rd quarter worth about $4,799,000. Sectoral Asset Management Inc. boosted its stake in Shoulder Innovations by 14.4% in the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after purchasing an additional 62,153 shares during the period. Readystate Asset Management LP bought a new position in Shoulder Innovations in the 3rd quarter worth about $511,000. Monashee Investment Management LLC bought a new position in Shoulder Innovations in the 3rd quarter worth about $502,000. Finally, CM Management LLC bought a new position in Shoulder Innovations in the 4th quarter worth about $358,000.

Wall Street Analysts Forecast Growth

SI has been the subject of a number of recent analyst reports. BTIG Research upped their price objective on Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, March 11th. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $21.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.